Combinational Environmental Chemicals Altering Susceptibility for Mammary Cancer
组合环境化学物质改变乳腺癌的易感性
基本信息
- 批准号:8472494
- 负责人:
- 金额:$ 41.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-27 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectApoptosisBiological AssayBloodBody measure procedureBody of uterusCandidate Disease GeneCell ProliferationChemical ExposureChemicalsComplexComplex MixturesCoupledCpG IslandsDNADNA MethylationDataDevelopmentDietDoseEarly identificationEnvironmentEpigenetic ProcessEtiologyExposure toGenesGenisteinGenomicsGoalsHumanImmunohistochemistryLifeMammary NeoplasmsMammary glandMeasuresMethylationMorphologyOralPlayPredispositionPreventionPrincipal InvestigatorProteinsRattusRecoveryRecruitment ActivityRegulationReportingResearchResearch PersonnelRodent ModelRoleSignal PathwayTechnologyToxic effectUrineVaginaWeightWestern Blottingbisphenol Acoralenvironmental chemicalgirlsin vivomalignant breast neoplasmphthalatesprepubertyprograms
项目摘要
DESCRIPTION (provided by applicant): Humans are exposed to a complex mixture of environmental chemicals. This is evident from the internal concentrations of these chemicals in humans, such as those from girls recruited via the Breast Cancer and the Environment Research Program. It is the investigators' goal to determine the potential of combinational, low dose exposures to three of these common environmental chemicals, administered orally in rats during the prepubertal period, to alter lifetime mammary cancer susceptibility. The investigators hypothesize that combinational exposure to Bisphenol A (BPA) and di-2-ethylhexyl phthalate (DEHP) will predispose for an additive or synergistic increase in mammary cancer development in a rodent model of mammary cancer. Furthermore, they will investigate the potential of genistein, when administered concurrently, to suppress the ability of BPA and DEHP to increase mammary cancer susceptibility. The specific aims are: 1) to determine if oral, prepubertal exposure to the combination of BPA and DEHP will result in an additive or synergistic increase in chemically-induced mammary cancer in rats, and if dietary genistein will result in negating the effects of BPA and DEHP; 2) to identify genomic signatures, via gene microarrays, from mammary glands of rats exposed to these chemicals to elucidate affected signaling pathways; 3) using the information from the gene array data and MIRA-seq (methylated CpG islands recovery assay coupled with massively parallel sequencing), the investigators will identify candidate DNA methylated genes and determine if prepubertal BPA, DEHP and genistein will effect epigenetic DNA methylation; 4) to investigate in vivo mechanisms of action at the cellular and protein levels (mammary gland morphology, cell proliferation, apoptosis and signaling pathways determined to be differentially regulated via gene array and eipigenetic assays); and 5) to measure concentrations of chemicals in blood and urine of rats exposed, alone or in combination, to BPA, DEHP and/or genistein during the prepubertal period. The identification of early life combinational chemical exposures commonly reported to occur in humans to alter mammary cancer susceptibility will facilitate our understanding of the complex role environmental chemicals play in breast cancer causation and prevention.
描述(申请人提供):人类暴露在一种复杂的环境化学品混合物中。这一点从这些化学物质在人体内的浓度可以明显看出,比如那些通过乳腺癌和环境研究计划招募的女孩身上的化学物质。研究人员的目标是确定在青春期前对大鼠口服三种常见环境化学物质的组合、低剂量暴露对改变终生乳腺癌易感性的可能性。研究人员假设,双酚A(BPA)和邻苯二甲酸二乙基己酯(DEHP)联合暴露于双酚A(BPA)和邻苯二甲酸二乙基己酯(DEHP)将有利于在乳腺癌啮齿动物模型中相加或协同增加乳腺癌的发生。此外,他们将研究金雀异黄素同时给药时抑制BPA和DEHP增加乳腺癌易感性的可能性。其具体目标是:1)确定口服、青春期前接触BPA和DEHP是否会导致化学诱导的大鼠乳腺癌的相加或协同增加,以及饮食金雀异黄素是否会导致BPA和DEHP的作用被否定;2)通过基因芯片,从暴露于这些化学物质的大鼠乳腺中识别基因组特征,以阐明受影响的信号通路;3)使用基因阵列数据和Mira-Seq(甲基化CpG岛恢复分析结合大规模平行测序)的信息,研究人员将识别候选DNA甲基化基因,并确定青春期前BPA、DEHP和istein是否会影响表观DNA甲基化;4)在细胞和蛋白质水平上研究BPA、DEHP和/或染料木素在体内的作用机制(乳腺形态、细胞增殖、细胞凋亡和通过基因芯片和表观遗传学分析确定的差异调控的信号通路);5)测量BPA、DEHP和/或染料木素在青春期前单独或联合暴露于大鼠血和尿中的化学物质浓度。识别早期生命中常见的组合化学暴露会改变乳腺癌的易感性,这将有助于我们理解环境化学物质在乳腺癌病因和预防中所起的复杂作用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Significance of rat mammary tumors for human risk assessment.
- DOI:10.1177/0192623314532036
- 发表时间:2015-02
- 期刊:
- 影响因子:1.5
- 作者:Russo J
- 通讯作者:Russo J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tim H.-M. Huang其他文献
ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer
- DOI:
10.1186/s12920-020-0729-7 - 发表时间:
2020-05-14 - 期刊:
- 影响因子:2.000
- 作者:
Chun-Lin Lin;Xi Tan;Meizhen Chen;Meena Kusi;Chia-Nung Hung;Chih-Wei Chou;Ya-Ting Hsu;Chiou-Miin Wang;Nameer Kirma;Chun-Liang Chen;Ching-Hung Lin;Kate I. Lathrop;Richard Elledge;Virginia G. Kaklamani;Kohzoh Mitsuya;Tim H.-M. Huang - 通讯作者:
Tim H.-M. Huang
Tim H.-M. Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tim H.-M. Huang', 18)}}的其他基金
PAI-1-mediated early-onset endometrial cancer
PAI-1介导的早发性子宫内膜癌
- 批准号:
10609901 - 财政年份:2021
- 资助金额:
$ 41.14万 - 项目类别:
PAI-1-mediated early-onset endometrial cancer
PAI-1介导的早发性子宫内膜癌
- 批准号:
10410371 - 财政年份:2021
- 资助金额:
$ 41.14万 - 项目类别:
Interrogating Epigenetic Changes in Cancer Genomes
探究癌症基因组的表观遗传变化
- 批准号:
8628066 - 财政年份:2014
- 资助金额:
$ 41.14万 - 项目类别:
Novel epigenetic paradigm in endometrial cancer recurrence
子宫内膜癌复发的新表观遗传学范例
- 批准号:
8755016 - 财政年份:2014
- 资助金额:
$ 41.14万 - 项目类别:
Novel epigenetic paradigm in endometrial cancer recurrence
子宫内膜癌复发的新表观遗传学范例
- 批准号:
9124596 - 财政年份:2014
- 资助金额:
$ 41.14万 - 项目类别:
Interrogating Epigenetic Changes in Cancer Genomes
探究癌症基因组的表观遗传变化
- 批准号:
8340013 - 财政年份:2011
- 资助金额:
$ 41.14万 - 项目类别:
Combinational Environmental Chemicals Altering Susceptibility for Mammary Cancer
组合环境化学物质改变乳腺癌的易感性
- 批准号:
8280369 - 财政年份:2010
- 资助金额:
$ 41.14万 - 项目类别:
Combinational Environmental Chemicals Altering Susceptibility for Mammary Cancer
组合环境化学物质改变乳腺癌的易感性
- 批准号:
8011571 - 财政年份:2010
- 资助金额:
$ 41.14万 - 项目类别:
Combinational Environmental Chemicals Altering Susceptibility for Mammary Cancer
组合环境化学物质改变乳腺癌的易感性
- 批准号:
8150389 - 财政年份:2010
- 资助金额:
$ 41.14万 - 项目类别:
Epigenomics of Bisphenol A Exposure and Disease Risk
双酚 A 暴露和疾病风险的表观基因组学
- 批准号:
7714035 - 财政年份:2009
- 资助金额:
$ 41.14万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 41.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 41.14万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 41.14万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




